AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/121
NONHEPARIN GLYCOSAMINOGLYCANS INDUCED GENERATION OF ANTIPLATELET FACTOR-4 HEPARIN ANTIBODIES - IMPLICATIONS IN THE MANAGEMENT OF HIT SYNDROME
Authors: FAREED J HOPPENSTEADT D JESKE W AMIRAL J WALENGA J
Citation: J. Fareed et al., NONHEPARIN GLYCOSAMINOGLYCANS INDUCED GENERATION OF ANTIPLATELET FACTOR-4 HEPARIN ANTIBODIES - IMPLICATIONS IN THE MANAGEMENT OF HIT SYNDROME, The FASEB journal, 12(5), 1998, pp. 4157-4157
TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CARDIOVASCULAR SYNDROMES
Authors: HOPPENSTEADT D FAREED J AMIRAL J JESKE W WALENGA J LEWIS B WELZEL D
Citation: D. Hoppensteadt et al., TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CARDIOVASCULAR SYNDROMES, The FASEB journal, 12(5), 1998, pp. 5532-5532
HIRUDIN DOES NOT PREVENT PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIC SYNDROMES
Authors: FAREED D FAREED J YANG L HOPPENSTEADT D JESKE W HAAS S MESSMORE H
Citation: D. Fareed et al., HIRUDIN DOES NOT PREVENT PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIC SYNDROMES, The FASEB journal, 12(4), 1998, pp. 1117-1117
HIRUDIN DOES NOT PREVENT PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIC SYNDROMES
Authors: FAREED D FAREED J YANG L HOPPENSTEADT D JESKE W HAAS S MESSMORE H
Citation: D. Fareed et al., HIRUDIN DOES NOT PREVENT PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIC SYNDROMES, Journal of the American College of Cardiology, 31(2), 1998, pp. 24-24
TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CORONARY SYNDROMES
Authors: HOPPENSTEADT D FAREED J AMIRAL J JESKE W WALENGA JM LEWIS B WELZEL D
Citation: D. Hoppensteadt et al., TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CORONARY SYNDROMES, Journal of the American College of Cardiology, 31(2), 1998, pp. 53-53
NON-HEPARIN GLYCOSAMINOGLYCANS-INDUCED GENERATION OF ANTIPLATELET FACTOR-4 HEPARIN ANTIBODIES - IMPLICATIONS IN THE MANAGEMENT OF HIT SYNDROME
Authors: FAREED J HOPPENSTEADT DA JESKE W AMIRAL J WALENGA JM
Citation: J. Fareed et al., NON-HEPARIN GLYCOSAMINOGLYCANS-INDUCED GENERATION OF ANTIPLATELET FACTOR-4 HEPARIN ANTIBODIES - IMPLICATIONS IN THE MANAGEMENT OF HIT SYNDROME, Clinical chemistry, 44, 1998, pp. 212-212
MEASUREMENT OF PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIA USING 3 COLOR-FLOW CYTOMETRY
Authors: JESKE W WOOD J SZATKOWSKI E BAKHOS M SHANKEY TV WALENGA JM
Citation: W. Jeske et al., MEASUREMENT OF PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIA USING 3 COLOR-FLOW CYTOMETRY, Clinical chemistry, 44, 1998, pp. 232-232
OPTIMIZATION OF LABORATORY ASSAYS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Authors: WOOD J JESKE W WALENGA JM
Citation: J. Wood et al., OPTIMIZATION OF LABORATORY ASSAYS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA, Clinical chemistry, 44, 1998, pp. 237-237
EFFECT OF ANTIPLATELET AGENTS ON THE HEPARIN-INDUCED THROMBOCYTOPENICSERUM-INDUCED ACTIVATION OF PLATELETS AS MEASURED BY FLOW-CYTOMETRY
Authors: WALENGA JM JESKE W HAAS S MESSMORE HL BAKHOS M
Citation: Jm. Walenga et al., EFFECT OF ANTIPLATELET AGENTS ON THE HEPARIN-INDUCED THROMBOCYTOPENICSERUM-INDUCED ACTIVATION OF PLATELETS AS MEASURED BY FLOW-CYTOMETRY, Clinical chemistry, 44, 1998, pp. 238-238
EVALUATION OF A POINT OF CARE ANTICOAGULATION ASSAY - THE HEPARIN-MANAGEMENT-TEST (HMT) DURING CARDIOPULMONARY BYPASS
Authors: WALLOCK M JESKE W WALENGA J IQBAL O BAKHOS M
Citation: M. Wallock et al., EVALUATION OF A POINT OF CARE ANTICOAGULATION ASSAY - THE HEPARIN-MANAGEMENT-TEST (HMT) DURING CARDIOPULMONARY BYPASS, Clinical chemistry, 44, 1998, pp. 305-305
LOW-MOLECULAR-WEIGHT HEPARINS - PHARMACOLOGICAL PROFILE AND PRODUCT DIFFERENTIATION
Authors: FAREED J JESKE W HOPPENSTEADT D CLARIZIO R WALENGA JM
Citation: J. Fareed et al., LOW-MOLECULAR-WEIGHT HEPARINS - PHARMACOLOGICAL PROFILE AND PRODUCT DIFFERENTIATION, The American journal of cardiology, 82(5B), 1998, pp. 3-10
MRI VERSUS CT IN THE DIAGNOSIS OF NELSONS SYNDROME
Authors: KASPERLIKZALUSKA A WALECKI J BRZEZINSKI J JESKE W MIGDALSKA B BONICKI W BRZEZINSKA A MAKOWSKA A
Citation: A. Kasperlikzaluska et al., MRI VERSUS CT IN THE DIAGNOSIS OF NELSONS SYNDROME, European radiology, 7(1), 1997, pp. 106-109
PLATELET ACTIVATION BY A NON-COAGULANT FORM OF THROMBIN (GAMMA) AND ITS INHIBITION BY GPIIB IIIA/
Authors: ERO M CALLAS D YANG L JESKE W FAREED J
Citation: M. Ero et al., PLATELET ACTIVATION BY A NON-COAGULANT FORM OF THROMBIN (GAMMA) AND ITS INHIBITION BY GPIIB IIIA/, The FASEB journal, 11(3), 1997, pp. 1825-1825
AN ANTIPLATELET DRUG, TICLOPIDINE, INHIBITS HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) RESPONSES AS MEASURED BY PLATELET AGGREGOMETRY AND C-14 SEROTONIN RELEASE
Authors: FAREED J JESKE W WALENGA JM YANG L ERO M LEWIS B
Citation: J. Fareed et al., AN ANTIPLATELET DRUG, TICLOPIDINE, INHIBITS HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) RESPONSES AS MEASURED BY PLATELET AGGREGOMETRY AND C-14 SEROTONIN RELEASE, Journal of the American College of Cardiology, 29(2), 1997, pp. 7121-7121
DEVELOPMENT OF A FLOW CYTOMETRIC ASSAY FOR THE LABORATORY DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Authors: JESKE W LEWIS BE SZATKOWSKI E FASANELLA A HAAS S WALENGA JM PIFARRE R
Citation: W. Jeske et al., DEVELOPMENT OF A FLOW CYTOMETRIC ASSAY FOR THE LABORATORY DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA, Thrombosis and haemostasis, 1997, pp. 1159-1159
GLYCOPROTEIN IIB IIIA INHIBITORS CAN PREVENT HEPARIN MEDIATED PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIA/
Authors: FAREED J YANG L BLAKEMORE C LEWIS BE JESKE W WALENGA JM HOPPENSTEADT D
Citation: J. Fareed et al., GLYCOPROTEIN IIB IIIA INHIBITORS CAN PREVENT HEPARIN MEDIATED PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIA/, Thrombosis and haemostasis, 1997, pp. 1484-1484
HEPARIN AND LMW HEPARIN NOT ONLY RELEASE TFPI FROM ENDOGENOUS VASCULAR SITES BUT ALSO FAVOR THE EQUILIBRIUM OF FREE TFPI
Authors: HOPPENSTEADT D JESKE W LEITZ H AMIRAL J WOLF H FAREED J
Citation: D. Hoppensteadt et al., HEPARIN AND LMW HEPARIN NOT ONLY RELEASE TFPI FROM ENDOGENOUS VASCULAR SITES BUT ALSO FAVOR THE EQUILIBRIUM OF FREE TFPI, Thrombosis and haemostasis, 1997, pp. 1673-1673
AN ANTIPLATELET DRUG, TICLOPIDINE, INHIBITS HEPARIN-INDUCED THROMBOCYTOPENIA RESPONSES AS MEASURED BY PLATELET AGGREGOMETRY AND C-14 SEROTONIN RELEASE
Authors: ERO M JESKE W WALENGA JM YANG L LEWIS BE FAREED J PIFARRE R
Citation: M. Ero et al., AN ANTIPLATELET DRUG, TICLOPIDINE, INHIBITS HEPARIN-INDUCED THROMBOCYTOPENIA RESPONSES AS MEASURED BY PLATELET AGGREGOMETRY AND C-14 SEROTONIN RELEASE, Thrombosis and haemostasis, 1997, pp. 1827-1827
VALIDITY OF THE LABORATORY METHODS FOR THE DIAGNOSIS OF HIT - COMPARATIVE-STUDIES ON C-14 SEROTONIN RELEASE, ANTI-HEPARIN PLATELET FACTOR-4ANTIBODIES, PLATELET AGGREGOMETRY, LUMINESCENCE AGGREGOMETRY AND FLOWCYTOMETRIC METHODS
Authors: WALENGA JM JESKE W LEWIS BE FABBRINI N YANG L SZATKOWSKI E FASANELLA A HAAS S MESSMORE HL PIFARRE R
Citation: Jm. Walenga et al., VALIDITY OF THE LABORATORY METHODS FOR THE DIAGNOSIS OF HIT - COMPARATIVE-STUDIES ON C-14 SEROTONIN RELEASE, ANTI-HEPARIN PLATELET FACTOR-4ANTIBODIES, PLATELET AGGREGOMETRY, LUMINESCENCE AGGREGOMETRY AND FLOWCYTOMETRIC METHODS, Thrombosis and haemostasis, 1997, pp. 1840-1840
PLATELET ACTIVATION BY A NON-COAGULANT FORM OF THROMBIN(GAMMA) AND ITS INHIBITION BY GPIIB IIIA/
Authors: CALLAS D ERO M YANG L JESKE W FAREED J
Citation: D. Callas et al., PLATELET ACTIVATION BY A NON-COAGULANT FORM OF THROMBIN(GAMMA) AND ITS INHIBITION BY GPIIB IIIA/, Thrombosis and haemostasis, 1997, pp. 2708-2708
CUSHINGS-SYNDROME SECONDARY TO ECTOPIC ACTH-SECRETION FROM A PRIMARY OVARIAN-CARCINOMA
Authors: KASPERLIKZAUSKA AA JESKE W MIGDALSKA B
Citation: Aa. Kasperlikzauska et al., CUSHINGS-SYNDROME SECONDARY TO ECTOPIC ACTH-SECRETION FROM A PRIMARY OVARIAN-CARCINOMA, Clinical endocrinology, 47(4), 1997, pp. 501-501
INCIDENTALLY DISCOVERED ADRENAL MASS (INCIDENTALOMA) - INVESTIGATION AND MANAGEMENT OF 208 PATIENTS
Authors: KASPERLIKZALUSKA AA ROSLONOWSKA E SLOWINSKASRZEDNICKA J MIGDALSKA B JESKE W MAKOWSKA A SNOCHOWSKA H
Citation: Aa. Kasperlikzaluska et al., INCIDENTALLY DISCOVERED ADRENAL MASS (INCIDENTALOMA) - INVESTIGATION AND MANAGEMENT OF 208 PATIENTS, Clinical endocrinology, 46(1), 1997, pp. 29-37
IN-VITRO STUDIES ON THE EFFECT OF ACTIVATED PROTEIN-C ON PLATELET ACTIVATION AND THROMBIN GENERATION
Authors: KAISER B JESKE W HOPPENSTEADT DH WALENGA JM DROHAN W FAREED J
Citation: B. Kaiser et al., IN-VITRO STUDIES ON THE EFFECT OF ACTIVATED PROTEIN-C ON PLATELET ACTIVATION AND THROMBIN GENERATION, Thrombosis research, 87(2), 1997, pp. 197-204
EFFECT OF HEPARINASE ON THE IN-VITRO RESPONSE OF PLATELETS TO HIT SERUM AS MEASURED BY PLATELET AGGREGOMETRY AND FLOW-CYTOMETRY
Authors: JESKE W SZATKOWSKI E ERO M CHINTHAGADA P FAREED J BAKHOS M WALENGA JM
Citation: W. Jeske et al., EFFECT OF HEPARINASE ON THE IN-VITRO RESPONSE OF PLATELETS TO HIT SERUM AS MEASURED BY PLATELET AGGREGOMETRY AND FLOW-CYTOMETRY, Blood, 90(10), 1997, pp. 2990-2990
DISSOCIATION BETWEEN PLASMA PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANTIPLATELET EFFECTS OF 2 GLYCOPROTEIN IIB IIIA ANTIBODIES IN A PRIMATE MODEL/
Authors: FAREED J YANG L FU K HOPPENSTEADT D JESKE W LEWIS B BREDDIN K
Citation: J. Fareed et al., DISSOCIATION BETWEEN PLASMA PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANTIPLATELET EFFECTS OF 2 GLYCOPROTEIN IIB IIIA ANTIBODIES IN A PRIMATE MODEL/, Blood, 90(10), 1997, pp. 3006-3006
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>